Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02885025 · ClinicalTrials.gov registry record · Phase 2
Effects of Broccoli Sprout Extract on Allergy Rhinitis
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT02885025: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT02885025 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02885025, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
Allergic rhinitis is a common illness suffered among US Veterans. There are medications that help relieve allergy symptoms, including nasal steroid sprays and antihistamines. Some patients have increase symptoms with exposure to their trigger, such as a grasses when combined with pollution due to oxidative stress from pollution. In this study, patients with allergic rhinitis to grass will be given broccoli sprout extract that contains an antioxidant sulforaphane do see if there is beneficial effect in these patients.
Interventions
- DIETARY_SUPPLEMENT Broccoli Sprout Extract
- DRUG fluticasone nasal
- DIETARY_SUPPLEMENT broccoli sprout extract placebo
- DRUG normal saline nasal spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2019-03-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02885025
The ClinicalTrials.gov registry entry for NCT02885025 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Broccoli Sprout Extract is the first listed.
NCT02885025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02885025 about?
NCT02885025 is a clinical study titled "Effects of Broccoli Sprout Extract on Allergy Rhinitis". Allergic rhinitis is a common illness suffered among US Veterans. There are medications that help relieve allergy symptoms, including nasal steroid sprays and antihistamines. Some patients have increase symptoms with exposure to their trigger, such as a grasses when combined with pollution due to ox...
What is the current status of trial NCT02885025?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2016-10-01. Estimated completion is 2019-03-12.
What interventions are being tested in trial NCT02885025?
The interventions under investigation include: Broccoli Sprout Extract (DIETARY_SUPPLEMENT), fluticasone nasal (DRUG), broccoli sprout extract placebo (DIETARY_SUPPLEMENT), normal saline nasal spray (DRUG).
Who is sponsoring clinical trial NCT02885025?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.